Literature DB >> 19706501

Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring.

Ian D Wilson1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19706501      PMCID： PMC2732874          DOI： 10.1073/pnas.0907721106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Pharmaco-metabonomic phenotyping and personalized drug treatment.

Authors:  T Andrew Clayton; John C Lindon; Olivier Cloarec; Henrik Antti; Claude Charuel; Gilles Hanton; Jean-Pierre Provost; Jean-Loïc Le Net; David Baker; Rosalind J Walley; Jeremy R Everett; Jeremy K Nicholson
Journal:  Nature       Date:  2006-04-20       Impact factor: 49.962

Review 2.  Gut microbiota: a potential new territory for drug targeting.

Authors:  Wei Jia; Houkai Li; Liping Zhao; Jeremy K Nicholson
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

3.  Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants.

Authors:  I Adlerberth; B Carlsson; P de Man; F Jalil; S R Khan; P Larsson; L Mellander; C Svanborg; A E Wold; L A Hanson
Journal:  Acta Paediatr Scand       Date:  1991 Jun-Jul

4.  Metabolic phenotyping in health and disease.

Authors:  Elaine Holmes; Ian D Wilson; Jeremy K Nicholson
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

5.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

6.  Microbial ecology: human gut microbes associated with obesity.

Authors:  Ruth E Ley; Peter J Turnbaugh; Samuel Klein; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

7.  Interethnic variation in the metabolic inactivation of digoxin by the gut flora.

Authors:  A N Alam; J R Saha; J F Dobkin; J Lindenbaum
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

8.  Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora.

Authors:  V I Mathan; J Wiederman; J F Dobkin; J Lindenbaum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

9.  Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol).

Authors:  F Y Ghauri; A E McLean; D Beales; I D Wilson; J K Nicholson
Journal:  Biochem Pharmacol       Date:  1993-09-01       Impact factor: 5.858

10.  Human disease classification in the postgenomic era: a complex systems approach to human pathobiology.

Authors:  Joseph Loscalzo; Isaac Kohane; Albert-Laszlo Barabasi
Journal:  Mol Syst Biol       Date:  2007-07-10       Impact factor: 11.429
View more
  21 in total

Review 1.  Microbiota and the control of blood-tissue barriers.

Authors:  Maha Al-Asmakh; Lars Hedin
Journal:  Tissue Barriers       Date:  2015-05-29

Review 2.  The intestinal microbiome and surgical disease.

Authors:  Monika A Krezalek; Kinga B Skowron; Kristina L Guyton; Baddr Shakhsheer; Sanjiv Hyoju; John C Alverdy
Journal:  Curr Probl Surg       Date:  2016-06-14       Impact factor: 1.909

Review 3.  Microbiome-wide association studies link dynamic microbial consortia to disease.

Authors:  Jack A Gilbert; Robert A Quinn; Justine Debelius; Zhenjiang Z Xu; James Morton; Neha Garg; Janet K Jansson; Pieter C Dorrestein; Rob Knight
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

4.  Real-time particle-by-particle detection of erythrocyte-camouflaged microsensor with extended circulation time in the bloodstream.

Authors:  Wenjun Di; Xuefei Tan; Isen Andrew C Calderon; Ashlyn E Neal Reilly; Mark Niedre; Heather A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-04       Impact factor: 11.205

5.  Understanding neonatal hypoxic-ischemic encephalopathy with metabolomics.

Authors:  N Efstathiou; G Theodoridis; K Sarafidis
Journal:  Hippokratia       Date:  2017 Jul-Sep       Impact factor: 0.471

6.  Genetic and chemical characterization of ibuprofen degradation by Sphingomonas Ibu-2.

Authors:  Robert W Murdoch; Anthony G Hay
Journal:  Microbiology       Date:  2013-01-17       Impact factor: 2.777

Review 7.  Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?

Authors:  Suzanne M Snedeker; Anthony G Hay
Journal:  Environ Health Perspect       Date:  2011-10-31       Impact factor: 9.031

8.  Tiny medicine: nanomaterial-based biosensors.

Authors:  Yeo-Heung Yun; Edward Eteshola; Amit Bhattacharya; Zhongyun Dong; Joon-Sub Shim; Laura Conforti; Dogyoon Kim; Mark J Schulz; Chong H Ahn; Nelson Watts
Journal:  Sensors (Basel)       Date:  2009-11-19       Impact factor: 3.576

9.  Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes.

Authors:  Rama Saad; Mariam R Rizkallah; Ramy K Aziz
Journal:  Gut Pathog       Date:  2012-11-30       Impact factor: 4.181

10.  Prediction of the pharmacokinetic parameters of triptolide in rats based on endogenous molecules in pre-dose baseline serum.

Authors:  Linsheng Liu; Bei Cao; Jiye Aa; Tian Zheng; Jian Shi; Mengjie Li; Xinwen Wang; Chunyan Zhao; Wenjing Xiao; Xiaoyi Yu; Runbin Sun; Rongrong Gu; Jun Zhou; Liang Wu; Gang Hao; Xuanxuan Zhu; Guangji Wang
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.